Article ; Online: Metastasis is impaired by endothelial-specific Dll4 loss-of-function through inhibition of epithelial-to-mesenchymal transition and reduction of cancer stem cells and circulating tumor cells.
Clinical & experimental metastasis
2019 Volume 36, Issue 4, Page(s) 365–380
Abstract: Systemic inhibition of Dll4 has been shown to thoroughly reduce cancer metastasis. The exact cause of this effect and whether it is endothelial mediated remains to be clarified. Therefore, we proposed to analyze the impact of endothelial Dll4 loss-of- ... ...
| Abstract | Systemic inhibition of Dll4 has been shown to thoroughly reduce cancer metastasis. The exact cause of this effect and whether it is endothelial mediated remains to be clarified. Therefore, we proposed to analyze the impact of endothelial Dll4 loss-of-function on metastasis induction on three early steps of the metastatic process, regulation of epithelial-to-mesenchymal transition (EMT), cancer stem cell (CSC) frequency and circulating tumor cell (CTC) number. For this, Lewis Lung Carcinoma (LLC) cells were used to model mouse tumor metastasis in vivo, by subcutaneous transplantation into endothelial-specific Dll4 loss-of-function mice. We observed that endothelial-specific Dll4 loss-of-function is responsible for the tumor vascular regression that leads to the reduction of tumor burden. It induces an increase in tumoral blood vessel density, but the neovessels are poorly perfused, with increased leakage and reduced perivascular maturation. Unexpectedly, although hypoxia was increased in the tumor, the number and burden of macro-metastasis was significantly reduced. This is likely to be a consequence of the observed reduction in both EMT and CSC numbers caused by the endothelial-specific Dll4 loss-of-function. This multifactorial context may explain the concomitantly observed reduction of the circulating tumor cell count. Furthermore, our results suggest that endothelial Dll4/Notch-function mediates tumor hypoxia-driven increase of EMT. Therefore, it appears that endothelial Dll4 may constitute a promising target to prevent metastasis. |
|---|---|
| MeSH term(s) | Adaptor Proteins, Signal Transducing/physiology ; Animals ; Calcium-Binding Proteins/physiology ; Carcinoma, Lewis Lung/blood supply ; Carcinoma, Lewis Lung/pathology ; Cell Hypoxia ; Endothelial Cells/physiology ; Epithelial-Mesenchymal Transition ; Mice ; Neoplasm Metastasis/prevention & control ; Neoplastic Cells, Circulating ; Neoplastic Stem Cells/physiology ; Platelet Endothelial Cell Adhesion Molecule-1/analysis ; Receptors, Notch/physiology ; Signal Transduction ; Tumor Burden |
| Chemical Substances | Adaptor Proteins, Signal Transducing ; Calcium-Binding Proteins ; DLL4 protein, human ; Pecam1 protein, mouse ; Platelet Endothelial Cell Adhesion Molecule-1 ; Receptors, Notch |
| Language | English |
| Publishing date | 2019-05-22 |
| Publishing country | Netherlands |
| Document type | Journal Article ; Research Support, Non-U.S. Gov't |
| ZDB-ID | 604952-7 |
| ISSN | 1573-7276 ; 0262-0898 |
| ISSN (online) | 1573-7276 |
| ISSN | 0262-0898 |
| DOI | 10.1007/s10585-019-09973-2 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1855: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.